DE60322856D1 - - Google Patents

Info

Publication number
DE60322856D1
DE60322856D1 DE60322856T DE60322856T DE60322856D1 DE 60322856 D1 DE60322856 D1 DE 60322856D1 DE 60322856 T DE60322856 T DE 60322856T DE 60322856 T DE60322856 T DE 60322856T DE 60322856 D1 DE60322856 D1 DE 60322856D1
Authority
DE
Germany
Prior art keywords
lower alkyl
alkyl group
group
chem
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60322856T
Other languages
English (en)
Inventor
Masayuki Nakamura
Jun Inoue
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senju Pharmaceutical Co Ltd
Original Assignee
Senju Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co Ltd filed Critical Senju Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE60322856D1 publication Critical patent/DE60322856D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/22—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
DE60322856T 2002-03-15 2003-03-14 Expired - Lifetime DE60322856D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002072762 2002-03-15
PCT/JP2003/003122 WO2003078415A1 (fr) 2002-03-15 2003-03-14 Derive de l'hemiacetal cyclique et son utilisation

Publications (1)

Publication Number Publication Date
DE60322856D1 true DE60322856D1 (de) 2008-09-25

Family

ID=28035193

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60322856T Expired - Lifetime DE60322856D1 (de) 2002-03-15 2003-03-14

Country Status (10)

Country Link
US (1) US7202274B2 (de)
EP (1) EP1489076B1 (de)
JP (2) JPWO2003078415A1 (de)
KR (1) KR101016593B1 (de)
CN (1) CN1297548C (de)
AT (1) ATE404548T1 (de)
AU (1) AU2003220928A1 (de)
DE (1) DE60322856D1 (de)
ES (1) ES2307915T3 (de)
WO (1) WO2003078415A1 (de)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0564561A4 (en) * 1990-12-28 1994-08-10 Georgia Tech Res Inst Peptides ketoamides, ketoacids, and ketoesters
RU94046058A (ru) 1992-05-20 1996-10-20 Сендзю Фармасьютикал Ко. Агент для лечения и профилактики катаракты, способ его получения, применение (+) - (2s, 3s)-3 (s)-3-метил-1-(3-метилбутилкарбомоил)бутилкарбамоил]-2-оксикарбоновой кислоты ее соли и ее этилового эфира для получения агента, способ лечения и профилактики катаракты, способ получения водного раствора
JP2825172B2 (ja) 1992-07-10 1998-11-18 東京エレクトロン株式会社 減圧処理装置および減圧処理方法
NO943210L (no) * 1993-09-03 1995-03-06 Takeda Chemical Industries Ltd Laktolderivater, deres fremstilling og anvendelse
JPH08104685A (ja) * 1993-09-03 1996-04-23 Takeda Chem Ind Ltd ラクトール誘導体、その製造法および用途
US5498616A (en) * 1994-11-04 1996-03-12 Cephalon, Inc. Cysteine protease and serine protease inhibitors
TW394764B (en) * 1995-02-14 2000-06-21 Mitsubishi Chemcal Corp Oxygen-containing heterocyclic derivatives
JPH09169752A (ja) * 1995-02-14 1997-06-30 Mitsubishi Chem Corp 含酸素複素環誘導体
ES2193615T3 (es) * 1995-10-25 2003-11-01 Senju Pharma Co .nhibidor de la angiogenesis.
WO1998004539A1 (fr) * 1996-07-29 1998-02-05 Mitsubishi Chemical Corporation Derives heterocycliques oxygenes

Also Published As

Publication number Publication date
ES2307915T3 (es) 2008-12-01
KR101016593B1 (ko) 2011-02-22
CN1297548C (zh) 2007-01-31
US20050119499A1 (en) 2005-06-02
KR20050006130A (ko) 2005-01-15
ATE404548T1 (de) 2008-08-15
WO2003078415A1 (fr) 2003-09-25
EP1489076A4 (de) 2005-12-21
EP1489076A1 (de) 2004-12-22
EP1489076B1 (de) 2008-08-13
JP2010189424A (ja) 2010-09-02
US7202274B2 (en) 2007-04-10
AU2003220928A1 (en) 2003-09-29
JPWO2003078415A1 (ja) 2005-07-14
CN1642933A (zh) 2005-07-20

Similar Documents

Publication Publication Date Title
BR0210030A (pt) Derivado de fenilpiridinacarbonilpiperazina
HK1069395A1 (en) Phthalazinone derivatives 2,3
HK1062885A1 (en) Spiropyrazole compounds
SI1385514T1 (sl) Spiroindenske in spiroindanske spojine
EP1380576A4 (de) Neue 1h-indazolverbindung
WO2005061458A3 (en) Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs
MY129188A (en) Metalloproteinase inhibitors
SI1385518T1 (sl) Benzimidazolonske spojine
ATE271045T1 (de) Sauerstoffhaltige heterocyclische verbindungen
WO2005063786A3 (en) Process for fluorocytidine derivatives
DK1031556T3 (da) 2-phenoxyanilinderivater
DK1209151T3 (da) 4-substituerede piperidinderivativer
HK1057215A1 (en) Benzo ÄbÄthiophene derivatives and process for producing the same
DE60230781D1 (en) Reverse hydroxamsäurederivate
DE60322856D1 (de)
EP1557407A4 (de) Neue alpha-ketoamidderivate und deren verwendung
IL170056A (en) Pyrazole compounds
EP1533312A4 (de) Heterobicyclische verbindungen
WO2003082837A1 (fr) Derive de l'hydroxymorpholinone et ses utilisations medicales
EP1693421A4 (de) Benzimidazolonverbindung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition